Wednesday, October 4, 2023
This special series of expert commentaries and interviews is part of a collaboration between Sanford-Burnham Medical Research Institute and Medscape and is designed to provide practicing clinicians with insight into how cutting-edge research from this world-famous research facility will translate into new diagnostic, prognostic, and therapeutic approaches to patient management in the near and far term.
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham, with operations in California and Florida, ranks among the top independent research institutions nationally for NIH grant funding and among the top organizations worldwide for its research impact. Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a nonprofit public benefit corporation. For more information, please visit www.sanfordburnham.org
